Vol 2025, No 3 (2025)

Table of Contents

Research & Development

Eli Lilly Signs US$1.2 B Collaboration with Magnet Biomedicine for Molecular Glue Therapeutics Abstract pdf html
Amit Kaushik
Takeda Signs US$816 M Collaboration with BridGene Biosciences for Small Molecule Drugs Abstract pdf html
Amit Kaushik

Licensing

Biogen Gains Rights to Stoke Therapeutics’ Zorevunersen for the Treatment of Dravet Syndrome Abstract pdf html
Naini Anand
AbbVie Enters Obesity Space Through US$2.2 B Licensing Pact with Gubra Abstract pdf html
Lucy Haggerty
Roche Pays Zealand Pharma US$1.65 B Upfront for Obesity Drug Petrelintide Abstract pdf html
Lucy Haggerty

Mergers & Acquisitions

Sanofi to Acquire Dren Bio’s Autoimmune Bispecific Antibody for US$1.9 B Abstract pdf html
Lucy Haggerty
Endo and Mallinckrodt Set to Unite Through a US$6.7 B Merger Abstract pdf html
Ayush Saxena

Opinion & Analysis

IQVIA Pharma Deals Review of 2024 Abstract pdf
Lucy Haggerty,Taskin Ahmed,Ayush Saxena & Shikha Kashyap


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.